TSHA

NASDAQ · Biotechnology

Taysha Gene Therapies Inc

Mid-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.56

+0.22 (+3.47%)

As of Aug 9, 10:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 17 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +827.7% upside

Low Target $45.99

Average Target $60.86

High Target $68.15

Current Price $6.56

Current
$6.56

Target
$60.86

$45.99 $60.86 avg $68.15

Scenario Analysis

Bear Case

$45.99

601.1%

Low target

Base Case

$60.86

+827.7%

Avg target

Bull Case

$68.15

+938.9%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$7.30

-10.1% from high

52-Week Low

$2.63

+149.4% from low

Target vs 52W High

$60.86

+733.7% vs high

Next Earnings Report

Aug 11, 2026 · After Market Close

Today

EPS Est: $-0.12

Earnings in today. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.0%